{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:18:32Z","timestamp":1783412312975,"version":"3.54.6"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program","award":["2022YFE0131600"],"award-info":[{"award-number":["2022YFE0131600"]}]},{"name":"the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010035"],"award-info":[{"award-number":["2024GXNSFBA010035"]}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["GuikeAB25069034"],"award-info":[{"award-number":["GuikeAB25069034"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32460144"],"award-info":[{"award-number":["32460144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Guangxi","award":["2025GXNSFAA069085"],"award-info":[{"award-number":["2025GXNSFAA069085"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515010143"],"award-info":[{"award-number":["2023A1515010143"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05432-z","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:55:03Z","timestamp":1781297703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and validation of a prognostic model for pancreatic cancer utilizing genes of tumor-associated neutrophils"],"prefix":"10.1007","volume":"17","author":[{"given":"Zhengrong","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengzhan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"5432_CR1","doi-asserted-by":"crossref","unstructured":"Loh CY et al. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells, 2019. 8: 10.","DOI":"10.3390\/cells8101118"},{"issue":"1","key":"5432_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5432_CR3","first-page":"230","volume":"115","author":"AA Vareedayah","year":"2018","unstructured":"Vareedayah AA, Alkaade S, Taylor JR. Pancreatic Adenocarcinoma Mo Med. 2018;115(3):230\u20135.","journal-title":"Pancreatic Adenocarcinoma Mo Med"},{"issue":"1","key":"5432_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-019-1103-2","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Mol Cancer. 2019;18(1):173.","journal-title":"Mol Cancer"},{"issue":"9","key":"5432_CR5","first-page":"851","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic Cancer: Rev Jama. 2021;326(9):851\u201362.","journal-title":"Pancreatic Cancer: Rev Jama"},{"issue":"8","key":"5432_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41419-024-06984-0","volume":"15","author":"M Xiao","year":"2024","unstructured":"Xiao M, et al. NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Cell Death Dis. 2024;15(8):620.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5432_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/0115665232320846240910055032","volume":"25","author":"M Dwivedi","year":"2025","unstructured":"Dwivedi M, et al. Target and Gene-Based Therapeutic Strategies against Pancreatic Cancer: Current and Future Prospects. Curr Gene Ther. 2025;25(4):417\u201332.","journal-title":"Curr Gene Ther"},{"key":"5432_CR8","doi-asserted-by":"crossref","unstructured":"Tian G, et al. Identifying ARRB2 as a prognostic biomarker and key player in the tumor microenvironment of pancreatic cancer through scPagwas methodology. Curr Gene Ther; 2025. 26(1):203-222","DOI":"10.2174\/0115665232427614250904061700"},{"issue":"12","key":"5432_CR9","first-page":"6176","volume":"13","author":"R Sturgeon","year":"2023","unstructured":"Sturgeon R, Goel P, Singh RK. Tumor-associated neutrophils in pancreatic cancer progression and metastasis. Am J Cancer Res. 2023;13(12):6176\u201389.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"5432_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nri3917","volume":"15","author":"K Minton","year":"2015","unstructured":"Minton K. Chemokines: Neutrophils leave a trail for T cells. Nat Rev Immunol. 2015;15(10):597.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5432_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI37223","volume":"120","author":"J Jablonska","year":"2010","unstructured":"Jablonska J, et al. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest. 2010;120(4):1151\u201364.","journal-title":"J Clin Invest"},{"key":"5432_CR12","doi-asserted-by":"publisher","first-page":"581457","DOI":"10.3389\/fonc.2020.581457","volume":"10","author":"L Kalafati","year":"2020","unstructured":"Kalafati L, et al. Neutrophils as Orchestrators in Tumor Development and Metastasis Formation. Front Oncol. 2020;10:581457.","journal-title":"Front Oncol"},{"issue":"1","key":"5432_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2.","journal-title":"Breast Cancer Res"},{"key":"5432_CR14","unstructured":"GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019. 4(12): 934\u2013947."},{"issue":"4","key":"5432_CR15","doi-asserted-by":"publisher","first-page":"e1009962","DOI":"10.1371\/journal.pcbi.1009962","volume":"18","author":"M Poorebrahim","year":"2022","unstructured":"Poorebrahim M, et al. Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors. PLoS Comput Biol. 2022;18(4):e1009962.","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"5432_CR16","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.21873\/anticanres.16743","volume":"43","author":"Y Song","year":"2023","unstructured":"Song Y, et al. Prognostic Value and the Immune Microenvironment-associated Role of SMAD4 in Pancreatic Adenocarcinoma. Anticancer Res. 2023;43(12):5393\u2013408.","journal-title":"Anticancer Res"},{"key":"5432_CR17","doi-asserted-by":"crossref","unstructured":"Liu Y, et al. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1\/AKT\/mTOR axis. Cell Death Disease; 2022. 13: 232.","DOI":"10.1038\/s41419-022-04669-0"},{"key":"5432_CR18","doi-asserted-by":"crossref","unstructured":"Sharma R, et al. Gene Therapy: Transforming the Battle Against Pancreatic Cancer. Curr Gene Ther; 2025. 26(1):152-159","DOI":"10.2174\/0115665232364196250131102330"},{"issue":"6","key":"5432_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/0109298665383781250624054915","volume":"32","author":"SL Ipek","year":"2025","unstructured":"Ipek SL, et al. Recombinant Expression of L-methioninase from Brevibacterium linens and Evaluation of its Anticarcinogenic Properties against MiaPaCa-2 Cells. Protein Pept Lett. 2025;32(6):451\u201364.","journal-title":"Protein Pept Lett"},{"issue":"4","key":"5432_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/0109298665363165250225100109","volume":"32","author":"R Kaviyaprabha","year":"2025","unstructured":"Kaviyaprabha R, et al. Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene. Protein Pept Lett. 2025;32(4):280\u201398.","journal-title":"Protein Pept Lett"},{"key":"5432_CR21","doi-asserted-by":"crossref","unstructured":"Deng J et al. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight, 2021. 6: 17.","DOI":"10.1172\/jci.insight.146133"},{"key":"5432_CR22","doi-asserted-by":"crossref","unstructured":"Zhou Z et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer. 2021. 9(3):e001946","DOI":"10.1136\/jitc-2020-001946"},{"issue":"14","key":"5432_CR23","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-09-3169","volume":"16","author":"N Saeki","year":"2010","unstructured":"Saeki N, et al. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin Cancer Res. 2010;16(14):3533\u20138.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"5432_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/sj.onc.1203426","volume":"19","author":"Z Gu","year":"2000","unstructured":"Gu Z, et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene. 2000;19(10):1288\u201396.","journal-title":"Oncogene"},{"issue":"16","key":"5432_CR25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pros.23432","volume":"77","author":"E Li","year":"2017","unstructured":"Li E, et al. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc. Prostate. 2017;77(16):1563\u201372.","journal-title":"Prostate"},{"issue":"33","key":"5432_CR26","doi-asserted-by":"publisher","first-page":"54592","DOI":"10.18632\/oncotarget.17523","volume":"8","author":"T Link","year":"2017","unstructured":"Link T, et al. Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2\/neu overexpression. Oncotarget. 2017;8(33):54592\u2013603.","journal-title":"Oncotarget"},{"issue":"3","key":"5432_CR27","first-page":"3081","volume":"15","author":"H Ono","year":"2018","unstructured":"Ono H, et al. Prostate stem cell antigen is expressed in normal and malignant human brain tissues. Oncol Lett. 2018;15(3):3081\u20134.","journal-title":"Oncol Lett"},{"issue":"1","key":"5432_CR28","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.bjorl.2024.101484","volume":"91","author":"G Yin","year":"2025","unstructured":"Yin G, et al. Analysis of the role of IL-1 family and related genes in head and neck squamous cell carcinoma. Braz J Otorhinolaryngol. 2025;91(1):101484.","journal-title":"Braz J Otorhinolaryngol"},{"key":"5432_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.biopha.2014.12.040","volume":"70","author":"F Tas","year":"2015","unstructured":"Tas F, et al. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer. Biomed Pharmacother. 2015;70:19\u201323.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"5432_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/2326-6066.CIR-23-0706","volume":"12","author":"A Menachem","year":"2024","unstructured":"Menachem A, et al. Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor Effects. Cancer Immunol Res. 2024;12(6):687\u2013703.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"5432_CR31","doi-asserted-by":"publisher","first-page":"20524","DOI":"10.1038\/s41598-022-25059-8","volume":"12","author":"Y Lv","year":"2022","unstructured":"Lv Y, et al. Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model. Sci Rep. 2022;12(1):20524.","journal-title":"Sci Rep"},{"issue":"19","key":"5432_CR32","doi-asserted-by":"publisher","first-page":"14803","DOI":"10.18632\/oncotarget.22976","volume":"9","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, et al. Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1\/PD-L1 pathway. Oncotarget. 2018;9(19):14803\u201314.","journal-title":"Oncotarget"},{"issue":"11","key":"5432_CR33","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/eji.201848070","volume":"49","author":"BR Sharma","year":"2019","unstructured":"Sharma BR, Karki R, Kanneganti TD. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol. 2019;49(11):1998\u20132011.","journal-title":"Eur J Immunol"},{"issue":"4","key":"5432_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19(4):197\u2013214.","journal-title":"Nat Rev Cancer"},{"issue":"28","key":"5432_CR35","doi-asserted-by":"publisher","first-page":"45825","DOI":"10.18632\/oncotarget.17573","volume":"8","author":"M Farshchian","year":"2017","unstructured":"Farshchian M, et al. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Oncotarget. 2017;8(28):45825\u201336.","journal-title":"Oncotarget"},{"key":"5432_CR36","doi-asserted-by":"crossref","unstructured":"Zheng P et al. The role of AIM2 in human hepatocellular carcinoma and its clinical significance. Pathol Res Pract, 2023. 245:154454.","DOI":"10.1016\/j.prp.2023.154454"},{"issue":"24","key":"5432_CR37","doi-asserted-by":"publisher","first-page":"36185","DOI":"10.18632\/oncotarget.9154","volume":"7","author":"X Ma","year":"2016","unstructured":"Ma X, et al. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway. Oncotarget. 2016;7(24):36185\u201397.","journal-title":"Oncotarget"},{"issue":"10","key":"5432_CR38","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/ijc.28891","volume":"135","author":"S Dihlmann","year":"2014","unstructured":"Dihlmann S, et al. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients. Int J Cancer. 2014;135(10):2387\u201396.","journal-title":"Int J Cancer"},{"key":"5432_CR39","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.2147\/IJGM.S369209","volume":"15","author":"C Li","year":"2022","unstructured":"Li C, et al. Construction of a Pyroptosis-Related Genes Signature to Improve the Prognostic Prediction and Therapeutic Drugs Selection in Patients with Pancreatic Cancer. Int J Gen Med. 2022;15:6387\u2013403.","journal-title":"Int J Gen Med"},{"key":"5432_CR40","doi-asserted-by":"publisher","first-page":"743377","DOI":"10.3389\/fmicb.2021.743377","volume":"12","author":"W Yao","year":"2021","unstructured":"Yao W, et al. A Valuable Product of Microbial Cell Factories: Microbial Lipase. Front Microbiol. 2021;12:743377.","journal-title":"Front Microbiol"},{"issue":"3","key":"5432_CR41","doi-asserted-by":"publisher","first-page":"e3504","DOI":"10.1002\/dmrr.3504","volume":"38","author":"YL Muller","year":"2022","unstructured":"Muller YL, et al. A missense variant Arg611Cys in LIPE which encodes hormone sensitive lipase decreases lipolysis and increases risk of type 2 diabetes in American Indians. Diabetes Metab Res Rev. 2022;38(3):e3504.","journal-title":"Diabetes Metab Res Rev"},{"key":"5432_CR42","doi-asserted-by":"publisher","first-page":"735993","DOI":"10.3389\/fonc.2021.735993","volume":"11","author":"X Gao","year":"2021","unstructured":"Gao X, et al. A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2021;11:735993.","journal-title":"Front Oncol"},{"key":"5432_CR43","doi-asserted-by":"publisher","first-page":"154844","DOI":"10.1016\/j.prp.2023.154844","volume":"251","author":"S Ghafouri-Fard","year":"2023","unstructured":"Ghafouri-Fard S, et al. Expression analysis of PPAR-related lncRNAs in breast cancer. Pathol Res Pract. 2023;251:154844.","journal-title":"Pathol Res Pract"},{"key":"5432_CR44","doi-asserted-by":"publisher","first-page":"639980","DOI":"10.3389\/fonc.2021.639980","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p\/MAPK Pathway. Front Oncol. 2021;11:639980.","journal-title":"Front Oncol"},{"key":"5432_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","volume":"40","author":"SM Downs-Canner","year":"2022","unstructured":"Downs-Canner SM, et al. B Cell Function in the Tumor Microenvironment. Annu Rev Immunol. 2022;40:169\u201393.","journal-title":"Annu Rev Immunol"},{"key":"5432_CR46","doi-asserted-by":"crossref","unstructured":"Sun Q et al. Leveraging single-cell RNA-seq for uncovering na\u00efve B cells associated with better prognosis of hepatocellular carcinoma. MedComm (2020). 2024. 5(9): e563.","DOI":"10.1002\/mco2.563"},{"issue":"1","key":"5432_CR47","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1186\/s12967-024-05963-5","volume":"22","author":"A Zabeti Touchaei","year":"2024","unstructured":"Zabeti Touchaei A, Vahidi S. Unraveling the interplay of CD8\u2009+\u2009T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches. J Transl Med. 2024;22(1):1131.","journal-title":"J Transl Med"},{"issue":"1","key":"5432_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12033-023-00733-y","volume":"66","author":"B Liu","year":"2024","unstructured":"Liu B, Liu Z, Gao C. Relationship Between CD8\u2009+\u2009T Cells and Prognosis of Esophageal Cancer Patients: A Systematic Review and Meta-analysis. Mol Biotechnol. 2024;66(1):138\u201350.","journal-title":"Mol Biotechnol"},{"issue":"12","key":"5432_CR49","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/eji.202149515","volume":"52","author":"P Stoitzner","year":"2022","unstructured":"Stoitzner P, et al. Antigen targeting to dendritic cells: Still a place in future immunotherapy? Eur J Immunol. 2022;52(12):1909\u201324.","journal-title":"Eur J Immunol"},{"issue":"6","key":"5432_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.62347\/GRYY2849","volume":"13","author":"MV Gulubova","year":"2024","unstructured":"Gulubova MV, et al. Tertiary lymphoid structures in colorectal cancer - organization and immune cell interactions. Am J Clin Exp Immunol. 2024;13(6):236\u201345.","journal-title":"Am J Clin Exp Immunol"},{"issue":"2","key":"5432_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5230\/jgc.2023.23.e19","volume":"23","author":"MQ Qiu","year":"2023","unstructured":"Qiu MQ, et al. Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor Immunity. J Gastric Cancer. 2023;23(2):340\u201354.","journal-title":"J Gastric Cancer"},{"issue":"5","key":"5432_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1615\/CritRevImmunol.2024052486","volume":"44","author":"T Nguyen","year":"2024","unstructured":"Nguyen T, et al. Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma. Crit Rev Immunol. 2024;44(5):71\u201385.","journal-title":"Crit Rev Immunol"},{"key":"5432_CR53","doi-asserted-by":"publisher","first-page":"750022","DOI":"10.3389\/fcell.2021.750022","volume":"9","author":"A Vuleti\u0107","year":"2021","unstructured":"Vuleti\u0107 A, et al. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer. Front Cell Dev Biol. 2021;9:750022.","journal-title":"Front Cell Dev Biol"},{"key":"5432_CR54","doi-asserted-by":"crossref","unstructured":"Seo D et al. Dihydrotestosterone enhances MICA-mediated immune responses to Epstein-Barr virus-associated gastric carcinoma. Cancers, 2024. 16(18):3219.","DOI":"10.3390\/cancers16183219"},{"key":"5432_CR55","unstructured":"Youssef M et al. Unraveling the therapeutic potential of GANT61\/Dactolisib combination as a novel prostate cancer modality. Med Oncol, 2022. 39: 10."},{"key":"5432_CR56","doi-asserted-by":"publisher","first-page":"0108","DOI":"10.34133\/hds.0108","volume":"4","author":"A Ogunleye","year":"2024","unstructured":"Ogunleye A, et al. Large-Scale Machine Learning Analysis Reveals DNA Methylation and Gene Expression Response Signatures for Gemcitabine-Treated Pancreatic Cancer. Health data Sci. 2024;4:0108.","journal-title":"Health data Sci"},{"issue":"8","key":"5432_CR57","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/2767-9764.CRC-23-0230","volume":"3","author":"HC Wilbur","year":"2023","unstructured":"Wilbur HC, et al. Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. Cancer Res Commun. 2023;3(8):1672\u20137.","journal-title":"Cancer Res Commun"},{"key":"5432_CR58","doi-asserted-by":"crossref","unstructured":"Christen D et al. The mTOR pathway controls phosphorylation of BRAF at T401. Cell Communication Signal, 2024. 22(1):428.","DOI":"10.1186\/s12964-024-01808-2"},{"issue":"5","key":"5432_CR59","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1158\/2767-9764.CRC-24-0036","volume":"4","author":"EI Buchbinder","year":"2024","unstructured":"Buchbinder EI, et al. A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer Res Commun. 2024;4(5):1321\u20137.","journal-title":"Cancer Res Commun"},{"issue":"8","key":"5432_CR60","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41565-023-01381-8","volume":"18","author":"MJ Baek","year":"2023","unstructured":"Baek MJ, et al. Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery. Nat Nanotechnol. 2023;18(8):945\u2013.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"5432_CR61","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4103\/jcrt.jcrt_1504_23","volume":"20","author":"YL Chen","year":"2024","unstructured":"Chen YL, et al. Antitumor activity of extracellular signal-regulated kinases 1\/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells. J Cancer Res Ther. 2024;20(2):570\u20137.","journal-title":"J Cancer Res Ther"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05432-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:02:39Z","timestamp":1783411359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05432-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5432"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05432-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients involved in the database have obtained ethical approval. The sample collection and informed consent of participants were implemented under the approval offered by the ethics committee of Yueyang Hospital affiliated to Hunan Normal University (approval number: 2025001). All procedures performed in this study were in accordance with the ethical standards of the Declaration of Helsinki (as revised in 2013). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"996"}}